{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:43:13Z","timestamp":1790005393316,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Cardiac abnormalities were frequently noted in patients with chronic kidney disease (CKD). This study is designed to assess whether echocardiographic parameters are associated with rate of renal function decline and progression to dialysis in CKD stage 3 to 5 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>This longitudinal study enrolled 415 patients. The renal end point was defined as commencement of dialysis. The change in renal function was measured by estimated GFR (eGFR) slope.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Progression to dialysis was predicted by wide pulse pressure, low albumin, low hemoglobin, high calcium-phosphorous product, proteinuria, diuretics use, and concentric left ventricular hypertrophy (LVH) (hazard ratio, 2.03; 95% confidence interval [CI], 1.00 to 4.10;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.05). The eGFR slope was negatively associated with total cholesterol, uric acid, proteinuria, diuretics use, and left atrial (LA) diameter (change in slope, \u22120.50; 95% CI, \u22120.89 to \u22120.11;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01) and positively associated with albumin and left ventricular ejection fraction (LVEF) (change in slope, 0.06; 95% CI, 0.03 to 0.08;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our study in patients of CKD stage 3 to 5 demonstrated that concentric LVH was associated with progression to dialysis, and that increased LA diameter and decreased LVEF were associated with\n                      <jats:italic toggle=\"yes\">faster<\/jats:italic>\n                      renal function decline. Echocardiography may help identify high-risk groups with progressive decline in renal function to dialysis and rapid progression of renal dysfunction in CKD stage 3 to 5 patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.04660511","type":"journal-article","created":{"date-parts":[[2011,10,7]],"date-time":"2011-10-07T02:03:57Z","timestamp":1317953037000},"page":"2750-2758","source":"Crossref","is-referenced-by-count":86,"title":["Echocardiographic Parameters are Independently Associated with Rate of Renal Function Decline and Progression to Dialysis in Patients with Chronic Kidney Disease"],"prefix":"10.2215","volume":"6","author":[{"given":"Szu-Chia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Ming","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chih","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Chia","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20230811","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"R2-6-20230811","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: A systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R3-6-20230811","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/HJH.0b013e3283424188","article-title":"Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events","volume":"29","author":"Cioffi","year":"2011","journal-title":"J Hypertens"},{"key":"R4-6-20230811","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/HJH.0b013e3283220ecd","article-title":"Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease","volume":"27","author":"Nardi","year":"2009","journal-title":"J Hypertension"},{"key":"R5-6-20230811","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.HYP.0000121223.44837.de","article-title":"Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients","volume":"43","author":"Muiesan","year":"2004","journal-title":"Hypertension"},{"key":"R6-6-20230811","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_1.29","article-title":"Left ventricular alterations and end-stage renal disease","volume":"17","author":"London","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R7-6-20230811","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000322709","article-title":"Left ventricular systolic strain in chronic kidney disease and hemodialysis patients","volume":"33","author":"Liu","year":"2011","journal-title":"Am J Nephrol"},{"key":"R8-6-20230811","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/treephys\/20.15.1029","article-title":"Photosynthetic capacity in relation to nitrogen in the canopy of a Quercus robur, Fraxinus angustifolia and Tilia cordata flood plain forest","volume":"20","author":"Kazda","year":"2000","journal-title":"Tree Physiol"},{"key":"R9-6-20230811","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Levey","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R10-6-20230811","first-page":"I34","article-title":"Phase-plane analysis of left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy","volume":"75","author":"Shimizu","year":"1987","journal-title":"Circulation"},{"key":"R11-6-20230811","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"R12-6-20230811","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R13-6-20230811","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.HYP.31.5.1077","article-title":"Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood","volume":"31","author":"de Simone","year":"1998","journal-title":"Hypertension"},{"key":"R14-6-20230811","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/ndt\/gfl249","article-title":"Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays?","volume":"21","author":"Vickery","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R15-6-20230811","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"R16-6-20230811","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1681\/ASN.2009050546","article-title":"Rapid decline of kidney function increases cardiovascular risk in the elderly","volume":"20","author":"Shlipak","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R17-6-20230811","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/diabetes.47.3.457","article-title":"Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration","volume":"47","author":"Veves","year":"1998","journal-title":"Diabetes"},{"key":"R18-6-20230811","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","article-title":"Left ventricular hypertrophy in nondiabetic predialysis CKD","volume":"46","author":"Paoletti","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R19-6-20230811","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1523-1755.2005.00072.x","article-title":"Electrocardiographic abnormalities and uremic cardiomyopathy","volume":"67","author":"Stewart","year":"2005","journal-title":"Kidney Int"},{"key":"R20-6-20230811","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ndt\/gfq409","article-title":"Is left ventricular hypertrophy a powerful predictor of progression to dialysis in chronic kidney disease?","volume":"26","author":"Paoletti","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R21-6-20230811","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9149(97)00948-X","article-title":"Left ventricular performance in the early stages of systemic hypertension. HARVEST Study Group. Hypertension and Ambulatory Recording Venetia Study","volume":"81","author":"Palatini","year":"1998","journal-title":"Am J Cardiol"},{"key":"R22-6-20230811","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0002-9149(99)00773-0","article-title":"Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint","volume":"85","author":"Wachtell","year":"2000","journal-title":"Am J Cardiol"},{"key":"R23-6-20230811","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: New perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"key":"R24-6-20230811","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000313718","article-title":"Cardiorenal syndromes: Definition and classification","volume":"164","author":"Ronco","year":"2010","journal-title":"Contrib Nephrol"},{"key":"R25-6-20230811","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.atherosclerosis.2008.08.016","article-title":"Clinical and subclinical cardiovascular disease and kidney function decline in the elderly","volume":"204","author":"Shlipak","year":"2009","journal-title":"Atherosclerosis"},{"key":"R26-6-20230811","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.jacc.2006.02.048","article-title":"Left atrial size: Physiologic determinants and clinical applications","volume":"47","author":"Abhayaratna","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R27-6-20230811","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2005.04.031","article-title":"Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: The Strong Heart Study (SHS)","volume":"151","author":"Kizer","year":"2006","journal-title":"Am Heart J"},{"key":"R29-6-20230811","doi-asserted-by":"crossref","first-page":"c341","DOI":"10.1159\/000321512","article-title":"Predictive factors associated with the period of time before Initiation of hemodialysis in CKD Stages 4 and 5","volume":"117","author":"Furukawa","year":"2011","journal-title":"Nephron Clin Pract"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201112000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:25Z","timestamp":1786369285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201112000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04660511","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}